VIVUS Up Again on Data (VVUS)

Posted in pre-market 
October 30th, 2009

VIVUS Inc. (NASDAQ: VVUS) is trading up this morning on additional data on its Qnexa, the obesity investigational drug candidate with data being presented at the annual scientific meeting of The Obesity Society.  While the company’s top-line data from the phase III studies was out in September, the presentation included data from the EQUIP and CONQUER studies and further supports the company and drug safety and efficacy profile.  At 8:24 AM EST we have seen 160,000 shares trade hands and the stock is up over 8% at $8.44.  The 52-week trading range here is $2.72 to $12.88.


Comments are closed